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Abstract
Neoplasms of the urinary bladder following augmentation ileocystoplasty are rare. We present the
case of a 39-year-old male with a tubular adenoma with high-grade dysplasia in the ileal segment 34
years after augmentation ileocystoplasty to enlarge a post-chemoradiation-induced shrunken
bladder. He presented with gross hematuria. Cystoscopy revealed a papillary tumor at the site of
ileovesical anastomosis, and transurethral resection was performed. Histologic examination
revealed a tubular adenoma with high-grade dysplasia. There are only two previous reports of
tubulovillous adenoma in ileal segment after ileocystoplasty, both without high-grade dysplasia. Our
observation supports the hypothesis that an ileal neobladder may undergo all the morphologic and
molecular changes observed in the development of gastrointestinal adenocarcinoma. Therefore,
patients who had an ileal neobladder created should be closely followed.
Background
Currently, the use of intestinal segments is the main
option both for augmentation and replacement of the uri-
nary bladder, and for diversion of urine from the normal
outlet in patients following cystectomy or post-therapy
shrunken bladder. These surgical procedures are separated
into two main groups, namely bladder substitution or
augmentation with transposed intestinal segments and
ureterosigmoidostomy. Several types of orthotopic blad-
der substitution or augmentation have been developed, of
which ileocystoplasty with the creation of an ileal neob-
ladder is one of the most common procedures. An ileal
neobladder is easily constructed and provides unchanged
voiding habits with good continence and upper urinary
tract preservation, with relatively low rates of complica-
tion [1]. Ureterosigmoidostomy is the surgical procedure
where the ureters are diverted into the fecal stream of the
sigmoid colon to allow the anal sphincter to maintain
both bowel and urinary continence.
There is now a general consensus from long-term follow-
up studies that ureterosigmoidostomy results in an
increased absolute risk of adenocarcinoma arising from
the ureterocolic anastomosis [1-5]. There is at present
insufficient conclusive evidence that ileocystoplasty is
responsible for an increased absolute risk of malignancy
[1]. A recent Cochrane meta-analytic review found few
prospective, randomized or case-control studies involving
the use of intestinal segments and none of these were
designed to assess the risk of secondary malignancy [6].
However, to date, there have been 10 reported cases of car-
cinomas developing in the ileal segment after ileocysto-
plasty in the English language medical literature [7-9].
There has been only 1 previous report of a tubulovillous
adenoma arising in the cecal segment after cecocysto-
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plasty, without high-grade dysplasia [10]. Finally, there
have been only 2 previous reports of tubulovillous ade-
noma developing in the ileal segment after augmentation
ileocystoplasty, both without high-grade dysplasia
[11,12]. We report the first case of a tubular adenoma with
high-grade dysplasia that developed in the ileal segment
34 years after augmentation ileocystoplasty.
Case presentation
A 39-year-old man underwent augmentation ileocysto-
plasty 34 years previously to enlarge his shrunken bladder
following chemotherapy and radiation therapy to his
bladder and prostate for embryonal rhabdomyosarcoma
at the age of 5. He was completely continent and was void-
ing normally after the augmentation ileocystoplasty. He
had no family history of gastrointestinal malignancy. He
presented with gross hematuria. A voiding cystogram
showed a polypoid mass at the level of the ileovesical
anastomosis. An intravenous pyelogram showed no evi-
dence of a mass or obstruction in the upper urinary tract.
Computerized tomography scans showed normal kidneys
without obstruction. Flexible cystoscopy revealed a soli-
tary 5 cm papillary tumor of the ileal segment in close
proximity of the site of ileovesical anastomosis. Transure-
thral loop resection was used to completely excise the
tumor to the underlying muscle. Histopathologic exami-
nation revealed a tubular adenoma with high-grade dys-
plasia (Figures 1A &1B), and the adjacent ileal mucosa
showed features of colonic metaplasia (Figure 1C). Based
on the patients's age of 39 (less than 50 years old), immu-
nohistochemical staining for the major DNA mismatch-
repair (MMR) proteins MLH1 and MSH2 was performed
to exclude the possiblity ofan inherited form of intestinal
neoplasia, hereditary non-polyposis colorectal cancer
(HNPCC). Immunohistochemical staining for MSH2 and
MLH1 revealed that the high-grade dysplastic ileal epithe-
lial cells retained both MSH2 (Figure 1D) and MLH1 (not
shown) expression, supporting anabsence of microsatel-
lite instability (MSI) in this neoplasm. Clinically, the
complete transurethral resection of the tumor was consid-
ered adequate conservative management, and he has
undergone follow-up cystoscopy at 3-month intervals for
the past year with no evidence of recurrence.
Discussion
Neoplastic changes after ureterosigmoidostomy as urinary
diversion are not uncommon, and these neoplasms are
generally attributed to the mixture of the urine and fecal
stream [1]. Several case series have been published on the
long-term follow-up of children with congenital malfor-
mation of the lower urinary tract who underwent ureter-
osigmoidostomy as urinary diversion. There is now a
general consensus from these studies that ureterosig-
moidostomy results in an increased absolute risk of aden-
ocarcinoma arising from the ureterocolic anastomosis [1-
5]. An estimated lifetime incidence of 5% to 19% for
malignant neoplasms following ureterosigmoidostomy
has been reported in these case series [1-3]. Approxi-
mately half of these malignant neoplasms are adenocarci-
nomas, and they tend to develop at the site of
anastomosis. A long latency period for the development
of neoplastic change was a consistent finding, with a
median of 26 years (range 5 to 50 years) [1,3].
Neoplasms developing after ileocystoplasty are indeed
rare; only 10 cases of carcinomas developing after ileo-
cystoplasty have been reported in the English language
medical literature [7-9]. However, their characteristics are
similar to those developing after ureterosigmoidostomy.
Of the 10 cases of carcinomas developing after ileocysto-
plasty, 8 were adenocarcinoma. In 8 of these 10 cases, the
tumor developed at the ileovesical junction, and in the
native bladder of the remaining 2 cases. The latent period
from the original surgery to the development of cancer
ranges from 4 to 32 years [7-9]. The peri-anastomotic
location of the tumor in the case herein presented is in
keeping with the above reported location of most tumors
arising after ileocystoplasty. Though the evidence for an
increased absolute risk of malignancy after ileocystoplasty
is inconclusive from meta-analytic review [6], our finding
of tubular adenoma with high-grade dysplasia and previ-
ous reports of adenocarcinomas in the ileal neobladder
[7-9] suggests that the development of gastrointestinal
malignancy after ileocystoplasty is a constant, low, but
still distinct, risk, even in the absence of mixture of the
urine and fecal stream. Since an estimated 153,270 new
cases of large bowel cancers occurred compared to an esti-
mated 6,170 new cases of small bowel cancers in the year
2006 (an approximately 25-fold difference in incidence)
[13], small intestinal urinary derivations are considered to
be at low risk of malignancy. Therefore, small bowel seg-
ments are being used increasingly in lower urinary tract
reconstruction.
Two main hypotheses have been proposed for the
increased risk of neoplastic changes following ureterosig-
moidostomy and ileocystoplasty [1,14,15]. The first
hypothesis, carcinogenic N-nitrosamine hypothesis, states
that the excessive production of N-nitrosamines of known
high carcinogenicity by the action of bacteria on urinary
nitrate activated malignant change [1,14]. N-nitrosamines
are produced when urinary nitrates are reduced to nitrites
by bacteria, especially by Escherichia coli. Nitrites and uri-
nary amines react to form N-nitrosamines. Experimental
studies using animal models have reported both support-
ive [14,16] and contradictory [17,18] evidence for this
hypothesis. It is generally believed that malignant change
occurring in association with urinary reconstruction using
intestinal segments is a result of urinary stagnation andDiagnostic Pathology 2007, 2:29 http://www.diagnosticpathology.org/content/2/1/29
Page 3 of 6
(page number not for citation purposes)
bacteriuria, chronic inflammation and carcinogenic sub-
stances, such as N-nitrosamine.
Ureterosigmoidostomy patients have consistently showed
substantially higher levels of N-nitrosamine in their faeces
or urine compared to control subjects, and was associated
with chronic inflammatory changes and altered mucin
secretion at the anastomotic site [5]. However, the admin-
istration of vitamin C (an inhibitor of N-nitrosamine for-
mation) in a subsequent small preliminary clinical study
resulted in only a modest, statistically insignificant,
decline in the N-nitrosamine content of rectal slurry [19].
Ileocystoplasty patients showed villous atrophy with
chronic inflammation and had high concentration of N-
nitrosamine in urine samples compared to control sub-
jects [20]. The levels of N-nitrosamines in the urine of
patients after augmentation ileocystoplasty have recently
been reported to be greatest among those with continued
urinary infection, those with sterile pyuria, those using
intermittent catheterization, and those not taking prophy-
lactic antibiotics [21]. The levels of N-nitrosamines within
urine from ileal neobladder are intermediate between
those found in normal controls and patients with ureter-
osigmoidostomy [21,22]. Additionally, a significantly
higher prevalence of bacteriuria (47%) has been reported
in patients after augmentation ileocystoplasty compared
to controls [20].
The second hypothesis, inflammatory response hypothe-
sis, states that the inflammatory response stimulated by
the anastomosis of differing mucosa lead to nuclear insta-
bility, perhaps through the generation of reactive oxygen
species [1,14]. However, direct supportive experimental
and clinical evidence for this hypothesis are lacking
[1,14,15]. One of the most intriguing facts of the previ-
ously reported cases of adenocarcinoma or tubular adeno-
mas [7-9] and of the present case of tubular adenoma with
high-grade dysplasia following ileocystoplasty is that
almost all tumors developed at the anastomotic site and
not elsewhere in the intestinal segment. Interestingly, the
same situation occurs in patients following ureterosig-
moidostomy where most adenocarcinomas developed at
the site of the anastomosis [1,3]. Additionally, though
spontaneous ileal malignancies are very rare, ileal malig-
nancies have been more frequently reported at the site of
surgical anastomosis such as ileo-ileostomy [23]. The
inflammatory response hypothesis has been suggested as
accounting for the increased susceptibility of develop-
ment of tumors at the line of anastomosis between the
intestinal segment and native bladder, but the supporting
evidence is inconclusive and the exact mechanism is not
well understood [1,14,15]. We hypothesize that the high-
est levels of carcinogenic N-nitrosamines are present clos-
est to the anastomosis (on account of stasis or reduced
motility at that site postoperatively) coupled with the
(A) Tubular adenoma with high-grade dysplasia (H&E, Original magnification × 40) Figure 1
(A) Tubular adenoma with high-grade dysplasia (H&E, Original magnification × 40). (B) Tubular adenoma with high-grade dys-
plasia (H&E, Original magnification ×100). (C) Tubular adenoma with adjacent colonic metaplasia (H&E, Original magnification 
× 40). (D) Both MSH2 (shown) and MLH1 (not shown) demonstrated intact (positive) nuclear staining in the dysplastic ileal 
epithelium (Immunoperoxidase, Original magnification × 200).Diagnostic Pathology 2007, 2:29 http://www.diagnosticpathology.org/content/2/1/29
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inflammatory response stimulated by the anastomosis of
differing mucosa lead to nuclear instability and the initia-
tion of the metaplasia-adenoma-carcinoma sequence.
However, additional long-term clinicohistological and
animal studies are required to confirm our hypotheis.
Clinical studies examining the cellular origin of tumors
found at the line of anastomosis between the intestinal
segment and native bladder have reported contradictory
findings [24,25]. Though, one study suggested the origin
of the adenocarcinoma from metaplastic bladder mucosa
[24], another study suggested that the neoplastic changes
were consistent with an intestinal origin on the basis of
histochemical staining [25]. In a follow-up prospective
study of 24 patients with orthotopic ileal neobladder who
underwent regular endoscopic biopsy for 5 years after sur-
gery, progressive changes to the ileal mucosa were seen,
with thinning, increased goblet cells, and villous atrophy,
but no dysplasia and no malignancy [26]. Three similar
studies of patients with orthotopic ileal neobladder (4-
year follow-up study of 30 patients [27], 7-year follow-up
study of 90 patients [28,29], and 10-year follow-up study
of 20 patients [30]) found similar progressive changes to
the ileal mucosa, but with no atrophy, no dysplasia and
no malignancy. Additionally, histochemical staining
revealed the increased presence of mucin (sulfomucins
and sialomucins) immediately postoperatively which
gradually reduced with extended follow-up [26-30]. These
5 recent follow-up studies suggested that the ileal mucosal
changes were adaptive rather than premalignant [26-30].
Therefore, evidence in support of either of the two
hypotheses of pathogenesis for malignancies following
ureterosigmoidostomy and ileocystoplasty is incomplete
and conflicting [1,14-22,26-30]. Recent animal studies do
not suggest a significant role for nitrosamines as the carci-
nogenic agent [14,16-18], whilst histological studies have
not shown clear evidence of premalignant mucosal
change subsequent to inflammation of the anastomotic
site [26-30]. Although nitrosamine excretion and bacterial
load is increased in ileocystoplasty patients [20-22], this
does not seem to lead to features of premalignant mucosal
change during medium-term follow-up. Transposed intes-
tinal segments exposed to urine undergo a well-character-
ized series of adaptive changes toward a more transitional
phenotype over a period of 4–10 years [26-30]. Early
inflammatory changes associated with surgery and seen in
more acute animal models soon disappear without any
evidence of the continued secretion of abnormal sialomu-
cins [26-30]. These progressive changes result in a rela-
tively thin intestinal epithelium with villous atrophy but
without dysplastic or neoplastic features, although the
extent of sampling of clinical material is necessarily lim-
ited for ethical reasons [1,6,28]. However, our finding of
tubular adenoma with high-grade dysplasia adjacent to
adaptive colonic metaplasia 34 years after ileocystoplasty
and the previous report of adenocarcinoma 20 years after
ileocystoplasty [7] suggest that the adaptive changes may
progress to premalignant and malignant changes. There-
fore, the adaptive colonic changes observed up to 10 years
in the 5 studies above [26-30] may progress to premalig-
nant and malignant changes in the ileal mucosa as late
complications after ileocystoplasty. As with all malignan-
cies, the pathway for carcinogenesis following ureterosig-
moidostomy and ileocystoplasty is likely to be complex
and multifactorial, and requires additional long-term his-
tological studies to suggest further experimental
approaches.
Immunohistochemical, the high-grade dysplastic ileal
epithelial cells in the case herein presented expressed both
DNA MMR proteins MSH2 and MLH1. The presence of
protein expression of these 2 major human DNA MMR
proteins indicates the absence of pathogenic mutations in
these MMR genes and the absence of microsatellite insta-
bility (MSI) at this stage in this neoplastic process. There-
fore, MSI was not contributory to the pathogenesis of the
high-grade dysplastic adenomatous changes in the case
herein presented, but does not exclude the possibility that
MSI may contribute to the subsequent progression to
invasive adenocarcinoma. Indeed, a recent report docu-
mented increased microsatellite levels in urine from a
patient who developed an invasive adenocarcinoma
within an augmented bladder after cystoplasty [31]. Loss
of heterozygosity was identified in both urine and tumor
samples from this patient using PCR-based microsatellite
analysis, suggesting that urinary microsatellite analysis
may be useful as a monitoring tool to detect neoplastic
change in patients after augmentation cystoplasty [31].
It is well established that malignant transformation in
colonic carcinoma involves the transition from metapla-
sia, through benign adenoma (without high-grade dyspla-
sia), adenoma with high-grade dysplasia, carcinoma in
situ, and finally invasive adenocarcinoma. Tubular ade-
noma (with or without high-grade dysplasia) is a precur-
sor of gastrointestinal adenocarcinoma, and requires
complete surgical excision when encountered in small
bowel segments used for urinary tract reconstruction [1].
Tubular adenoma with high-grade dysplasia in an ileal
segment used for lower urinary tract reconstruction has
not been previously reported to our knowledge. There
have been only two previous reports of tubulovillous ade-
nomas in ileal segment after ileocystoplasty, both without
high-grade dysplasia [11,12]. There has been only 1 previ-
ous report of a tubulovillous adenoma arising in the cecal
segment after cecocystoplasty, without high-grade dyspla-
sia [10]. The case herein reported of tubular adenoma
with high-grade dysplasia supports the hypothesis that an
ileal neobladder may undergo all the morphologic andDiagnostic Pathology 2007, 2:29 http://www.diagnosticpathology.org/content/2/1/29
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molecular changes observed in the development of gas-
trointestinal adenocarcinoma. The previous reports of
adenocarcinomas [7-9] and adenomas [11,12], and our
finding of a tubular adenoma with high-grade dysplasia in
the ileal neobladder support the metaplasia-adenoma-
carcinoma sequence as the pathway for carcinogenesis fol-
lowing ileocystoplasty. Therefore, we recommend that
patients with transposed intestinal neobladders need to
be screened for the development of adenomatous polyps
and subsequent carcinomas.
Conclusion
Patients undergoing augmentation ileocystoplasty are at
increased risk of glandular malignancy in the ileal seg-
ment. Therefore, clinicians should be aware of the poten-
tial of malignant transformation developing in the
neobladder when cystoplasty with any kind of intestinal
segments are performed. Hence, emphasizing the impor-
tance of careful lifelong follow-up, including cystoscopy
and urine cytology, of all patients who undergo urinary
tract reconstruction with small bowel segments.
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